Your browser doesn't support javascript.
loading
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.
Rescigno, Pasquale; Lorente, David; Bianchini, Diletta; Ferraldeschi, Roberta; Kolinsky, Michael P; Sideris, Spyridon; Zafeiriou, Zafeiris; Sumanasuriya, Semini; Smith, Alan D; Mehra, Niven; Jayaram, Anuradha; Perez-Lopez, Raquel; Mateo, Joaquin; Parker, Chris; Dearnaley, David P; Tunariu, Nina; Reid, Alison; Attard, Gerhardt; de Bono, Johann S.
Afiliação
  • Rescigno P; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Lorente D; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Bianchini D; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Ferraldeschi R; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Kolinsky MP; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Sideris S; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Zafeiriou Z; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Sumanasuriya S; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Smith AD; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Mehra N; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Jayaram A; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Perez-Lopez R; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Mateo J; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Parker C; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Dearnaley DP; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Tunariu N; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Reid A; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Attard G; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • de Bono JS; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.
Eur Urol ; 70(5): 724-731, 2016 11.
Article em En | MEDLINE | ID: mdl-26965561
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article